We have shown that higher DLL1 levels correlate with poor prognosis in ERα+ luminal tumors (Fig. 1c) and that high DLL1 drives ERα+, but not ERα− tumor growth, progression, and metastasis (Figs. 2−4). The gene discussed is ESR1; the disease is neoplasm.